Abstract
A 46-year-old woman presented with malignant ophthalmopathy 1 week after a therapeutic dose of radioiodine for treatment of hyperthyroidism. The patient was a smoker and had clinical evidence of mild thyroid-associated ophthalmopathy (TAO) prior to treatment with radioiodine. Anti-thyrotropin (TSH) receptor antibodies and antiflavoprotein antibodies were not detected at the time of presentation with malignant ophthalmopathy. The patient responded rapidly to anti-inflammatory treatment with intravenous methylprednisolone and orbital radiation.
Original language | English (US) |
---|---|
Pages (from-to) | 189-192 |
Number of pages | 4 |
Journal | Thyroid |
Volume | 9 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1999 |